Pudilan Xiaoyan Oral Liquid and Pudilan Children's Toothpaste Included in "Expert Consensus on Management of Mucosal Injury Repair in Children"
Recently, the "Expert Consensus on Management of Mucosal Injury Repair in Children" (hereinafter referred to as the "Consensus"), led by the Committee on Pediatric Allergy of the China Maternal and Child Health Association and developed by nearly 20 experts in dermatology, allergology, and...
Two Stars Shine: JumpCan Pharmaceutical's Pudilan and Tongpei Listed on "2025 Healthy China · Brand List"
From August 17 to 20, the 18th Health Industry Ecological Platform (CPEO Summit) was grandly held in Boao, Hainan, where authoritative brand awards of great industry interest were announced. JumpCan Pharmaceutical's exclusive formulation product Pudilan Xiaoyan Oral Liquid and exclusive...
One-Dose Full-Course: Anti-Influenza Class 1 Innovative Drug Jikeshu Approved for Market Launch
On July 18, the Class 1 innovative drug Jikeshu (generic name: Maxiluoshavir Tablets) was officially approved for marketing by the National Medical Products Administration (NMPA). It is indicated for the treatment of uncomplicated influenza A and B in otherwise healthy adults. Jikeshu is a new-generation...
JumpCan Pharmaceutical Expands Digestive Portfolio with New Product Approval! Compound Polyethylene Glycol (3350) Electrolyte Powder Approved
Recently, JumpCan Pharmaceutical received the Drug Registration Certificates issued by the National Medical Products Administration (NMPA) for Compound Polyethylene Glycol (3350) Electrolyte Powder in two specifications (6.9g/bag and 13.9g/bag). This new addition further enriches the...
JumpCan Pharmaceutical's Class 1.1 Innovative TCM Drug Xiao'er Biantong Granules Has Marketing Application Accepted
Recently, JumpCan Pharmaceutical received the "Acceptance Notice" from the National Medical Products Administration (NMPA) for the marketing application of its Class 1.1 innovative traditional Chinese medicine (TCM) drug Xiao'er Biantong Granules. Derived from a renowned physician's proven...
JumpCan Pharmaceutical's Class 1.1 Innovative TCM Drug Xiao'er Biantong Granules Has Marketing Application Accepted
Recently, Jumpcan Pharmaceutical received the "Acceptance Notice" from the National Medical Products Administration (NMPA) for the marketing application of its Class 1.1 innovative traditional Chinese medicine (TCM) drug Xiao'er Biantong Granules. Derived from a renowned physician's proven...
JumpCan Pharmaceutical 's Smart Factory Selected for Jiangsu Provincial Advanced-Level List
Recently, the Department of Industry and Information Technology of Jiangsu Province officially announced the list of "2025 Jiangsu Provincial Advanced-Level Smart Factories". Jumpcan Pharmaceutical was successfully selected for its project titled "Smart Factory for Traditional Chinese Medicine...
Pudilan Xiaoyan Oral Liquid Wins "Most Popular Star Product in Pharmacies" Award
From April 8 to 12, the 2025 Wuzhen Health Conference and the 4th China OTC Conference were grandly held. During the event, several authoritative industry awards were presented. Pudilan Xiaoyan Oral Liquid was honored with the "West Lake Award · the Most Popular Star Product in Pharmacies" in...
Two Products Shine Together: JumpCan Pharmaceutical's Pudilan and Tongpei Listed on China's Pharmaceutical Retail Market Brand List
From March 14 to 18, the 10th Health Industry Ecological Platform (PHCF) was grandly held in Huzhou, Zhejiang. The event brought together tens of thousands of industry professionals and witnessed the announcement of several authoritative awards. Among them, Pudilan Xiaoyan Oral Liquid...
JumpCan Pharmaceutical's Minfeile Honored as "Annual Trailblazing Innovation Star"
Recently, at the 2024 5th Lunjian · Annual Star Awards ceremony guided by the China Pharmaceutical News Information Association and hosted by Jianshiju, JumpCan Pharmaceutical's Minfeile (Fexofenadine Hydrochloride for Suspension)—the first of its kind approved in China—was recognized...